Kyowa Kirin to Invest $530M in New North American Biologics Manufacturing Facility

Kyowa Kirin Inc.’s board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.

The 171,700-square-foot, two-reactor facility will accelerate the company’s development and production of biologic therapies for patients with rare and serious diseases.